Accolate and Osteopenia - a phase IV clinical study of FDA data

Summary:

Osteopenia is reported as a side effect among people who take Accolate (zafirlukast), especially for people who are female, 50-59 old, have been taking the drug for 2 - 5 years also take Flovent, and have Chronic myeloid leukaemia.

The phase IV clinical study analyzes which people have Osteopenia when taking Accolate. It is created by eHealthMe based on reports of 4,145 people who have side effects when taking Accolate from the FDA, and is updated regularly.

What is Accolate?

Accolate has active ingredients of zafirlukast. It is often used in asthma. eHealthMe is studying from 4,220 Accolate users. Check the latest studies of Accolate.

What is Osteopenia?

Osteopenia (a condition where bone mineral density is lower than normal) is found to be associated with 1,446 drugs and 1,170 conditions by eHealthMe. Check the latest studies of Osteopenia.

On Jul, 06, 2026

4,145 people reported to have side effects when taking Accolate.
Among them, 19 people (0.46%) have Osteopenia.

Among these 19 people:

How long have people been on Accolate when they have Osteopenia? *

What is the gender of people who have Osteopenia when taking Accolate? *

female: 94.74 %
male: 5.26 %

What is the age of people who have Osteopenia when taking Accolate? *

What are other drugs people take besides Accolate? *

What are other side effects people have besides Osteopenia? *

Nausea (feeling of having an urge to vomit): 11 people, 57.89%
Indigestion: 11 people, 57.89%
Cardiac Murmur (an heart sound in valve abnormality): 10 people, 52.63%
Nausea And Vomiting: 10 people, 52.63%
Pain In Extremity: 9 people, 47.37%
Bone Pain: 9 people, 47.37%
High Blood Cholesterol: 8 people, 42.11%
Hypoaesthesia (reduced sense of touch or sensation): 8 people, 42.11%
Depression: 8 people, 42.11%
Joint Pain: 7 people, 36.84%

What are the existing conditions these people have? *

High Blood Cholesterol: 6 people, 31.58%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 6 people, 31.58%
Osteoporosis (bones weak and more likely to break): 5 people, 26.32%
Diabetes: 3 people, 15.79%
Skin Ulcer: 3 people, 15.79%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 10.53%
Hormone Level Abnormal: 2 people, 10.53%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 5.26%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 5.26%
Breast Cancer Female: 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Accolate and have Osteopenia?

- Check whether Osteopenia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Accolate:

Accolate (4,220 reports)

Osteopenia treatments and more:

Osteopenia (46,948 reports)

Browse all side effects of Accolate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Osteopenia:

Osteopenia (1,446 drugs)

Browse all the conditions that are associated with Osteopenia:

Osteopenia (1,170 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on zafirlukast (the active ingredients of Accolate) and Accolate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.